This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3
Vocabulary Work Group | Maturity Level: N/A | Ballot Status: Informative |
FHIR Value set/code system definition for HL7 v2 table 0292 ( Vaccines Administered (code = CVX) (parenteral, un)
<ValueSet xmlns="http://hl7.org/fhir"> <id value="v2-0292"/> <meta> <profile value="http://hl7.org/fhir/StructureDefinition/shareablevalueset"/> </meta> <text> <status value="additional"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p> Vaccines Administered (code = CVX) (parenteral, un</p> <table class="grid"> <tr> <td> <b> Code</b> </td> <td> <b> Description</b> </td> <td> <b> Nederlands (Dutch)</b> </td> <td> <b> Comment</b> </td> <td> <b> Version</b> </td> </tr> <tr> <td> 01 <a name="01"> </a> </td> <td> DTP</td> <td> DKT - difterie-kinkhoest-tetanus</td> <td> diphtheria, tetanus toxoids and pertussis vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 02 <a name="02"> </a> </td> <td> OPV</td> <td> OPV</td> <td> poliovirus vaccine, live, oral</td> <td> added v2.3</td> </tr> <tr> <td> 03 <a name="03"> </a> </td> <td> MMR</td> <td> BMR - bof, mazelen, rodehond</td> <td> measles, mumps and rubella virus vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 04 <a name="04"> </a> </td> <td> M/R</td> <td> M/R</td> <td> measles and rubella virus vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 05 <a name="05"> </a> </td> <td> measles</td> <td> mazelen</td> <td> measles virus vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 06 <a name="06"> </a> </td> <td> rubella</td> <td> rodehond</td> <td> rubella virus vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 07 <a name="07"> </a> </td> <td> mumps</td> <td> bof</td> <td> mumps virus vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 08 <a name="08"> </a> </td> <td> Hep B, adolescent or pediatric</td> <td> Hep B, adolescent of pediatrie</td> <td> hepatitis B vaccine, pediatric or pediatric/adolescent dosage</td> <td> added v2.3</td> </tr> <tr> <td> 09 <a name="09"> </a> </td> <td> Td (adult)</td> <td> DT - difterie en tetanus (volwassene)</td> <td> tetanus and diphtheria toxoids, adsorbed for adult use</td> <td> added v2.3</td> </tr> <tr> <td> 10 <a name="10"> </a> </td> <td> IPV</td> <td> IPV</td> <td> poliovirus vaccine, inactivated</td> <td> added v2.3</td> </tr> <tr> <td> 100 <a name="100"> </a> </td> <td> pneumococcal conjugate</td> <td> pneumokokken conjugaat</td> <td> pneumococcal conjugate vaccine, polyvalent</td> <td> added v2.4</td> </tr> <tr> <td> 101 <a name="101"> </a> </td> <td> typhoid, ViCPs</td> <td> tyfus, ViCPs</td> <td> typhoid Vi capsular polysaccharide vaccine</td> <td> added v2.4</td> </tr> <tr> <td> 102 <a name="102"> </a> </td> <td> DTP-Hib-Hep B</td> <td> DKT-Hib-Hep B</td> <td> DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine</td> <td> added v2.5</td> </tr> <tr> <td> 103 <a name="103"> </a> </td> <td> meningococcal C conjugate</td> <td> meningokokken C conjugaat</td> <td> meningococcal C conjugate vaccine</td> <td> added v2.5</td> </tr> <tr> <td> 104 <a name="104"> </a> </td> <td> Hep A-Hep B</td> <td> Hep A-Hep B</td> <td> hepatitis A and hepatitis B vaccine</td> <td> added v2.5</td> </tr> <tr> <td> 105 <a name="105"> </a> </td> <td> vaccinia (smallpox) diluted</td> <td> vaccinia (pokken) verzwakt</td> <td> vaccinia (smallpox) vaccine, diluted</td> <td> added v2.5</td> </tr> <tr> <td> 106 <a name="106"> </a> </td> <td> DTaP, 5 pertussis antigens6</td> <td> DaKT, 5 kinkhoest antigenen6</td> <td> diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens</td> <td> added v2.5</td> </tr> <tr> <td> 107 <a name="107"> </a> </td> <td> DTaP, NOS</td> <td> DaKT, niet anders gespecificeerd</td> <td> diphtheria, tetanus toxoids and acellular pertussis vaccine, NOS</td> <td> added v2.5</td> </tr> <tr> <td> 108 <a name="108"> </a> </td> <td> meningococcal, NOS</td> <td> meningokokken, niet anders gespecificeerd</td> <td> meningococcal vaccine, NOS</td> <td> added v2.5</td> </tr> <tr> <td> 109 <a name="109"> </a> </td> <td> pneumococcal, NOS</td> <td> pneumokokken, niet anders gespecificeerd</td> <td> pneumococcal vaccine, NOS</td> <td> added v2.5</td> </tr> <tr> <td> 11 <a name="11"> </a> </td> <td> pertussis</td> <td> kinkhoest</td> <td> pertussis vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 110 <a name="110"> </a> </td> <td> DTaP-Hep B-IPV</td> <td> DaKT-Hep B-IPV</td> <td> DTaP-hepatitis B and poliovirus vaccine</td> <td> added v2.6</td> </tr> <tr> <td> 111 <a name="111"> </a> </td> <td> influenza, live, intranasal</td> <td> influenza, levend, intranasaal</td> <td> influenza virus vaccine, live, attenuated, for intranasal use</td> <td> added v2.6</td> </tr> <tr> <td> 112 <a name="112"> </a> </td> <td> tetanus toxoid, NOS</td> <td> tetanus toxoïde, niet anders gespecificeerd</td> <td> tetanus toxoid, NOS</td> <td> added v2.6</td> </tr> <tr> <td> 113 <a name="113"> </a> </td> <td> Td (adult)</td> <td> DT - difterie en tetanus (volwassene)</td> <td> tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use</td> <td> added v2.6</td> </tr> <tr> <td> 114 <a name="114"> </a> </td> <td> meningococcal A,C,Y,W-135 diphtheria conjugate</td> <td> meningokokken A,C,Y,W-135 difterie conjugaat</td> <td> meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4)</td> <td> added v2.6</td> </tr> <tr> <td> 115 <a name="115"> </a> </td> <td> Tdap</td> <td> tetanus toxoïde, verminderde difterie toxoïde, en acellulaire kinkhoest</td> <td> tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed</td> <td> added v2.6</td> </tr> <tr> <td> 116 <a name="116"> </a> </td> <td> rotavirus, pentavalent</td> <td> rotavirus, pentavalent</td> <td> rotavirus, live, pentavalent vaccine</td> <td> added v2.6</td> </tr> <tr> <td> 117 <a name="117"> </a> </td> <td> VZIG (IND)</td> <td> VZIG (IND)</td> <td> varicella zoster immune globulin (Investigational New Drug)</td> <td> added v2.6</td> </tr> <tr> <td> 118 <a name="118"> </a> </td> <td> HPV, bivalent</td> <td> HPV, bivalent</td> <td> human papilloma virus vaccine, bivalent</td> <td> added v2.6</td> </tr> <tr> <td> 119 <a name="119"> </a> </td> <td> rotavirus, monovalent</td> <td> rotavirus, monovalent</td> <td> rotavirus, live, monovalent vaccine</td> <td> added v2.6</td> </tr> <tr> <td> 12 <a name="12"> </a> </td> <td> diphtheria antitoxin</td> <td> difterie antitoxine</td> <td> diphtheria antitoxin</td> <td> added v2.3</td> </tr> <tr> <td> 120 <a name="120"> </a> </td> <td> DTaP-Hib-IPV</td> <td> DaKT-Hib-IPV</td> <td> diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)</td> <td> added v2.6</td> </tr> <tr> <td> 121 <a name="121"> </a> </td> <td> zoster</td> <td> gordelroos</td> <td> zoster vaccine, live</td> <td> added v2.6</td> </tr> <tr> <td> 122 <a name="122"> </a> </td> <td> rotavirus, NOS1</td> <td> rotavirus, niet anders gespecificeerd1</td> <td> rotavirus vaccine, NOS</td> <td> added v2.6</td> </tr> <tr> <td> 13 <a name="13"> </a> </td> <td> TIG</td> <td> TIG</td> <td> tetanus immune globulin</td> <td> added v2.3</td> </tr> <tr> <td> 14 <a name="14"> </a> </td> <td> IG, NOS</td> <td> IG, niet anders gespecificeerd</td> <td> immune globulin, NOS</td> <td> added v2.3</td> </tr> <tr> <td> 15 <a name="15"> </a> </td> <td> influenza, split (incl. purified surface antigen)</td> <td> influenza, gesplitst (incl. gezuiverd oppervlakte antigen)</td> <td> influenza virus vaccine, split virus (incl. purified surface antigen)</td> <td> added v2.3</td> </tr> <tr> <td> 16 <a name="16"> </a> </td> <td> influenza, whole</td> <td> influenza, geheel</td> <td> influenza virus vaccine, whole virus</td> <td> added v2.3</td> </tr> <tr> <td> 17 <a name="17"> </a> </td> <td> Hib, NOS</td> <td> Hib, niet anders gespecificeerd</td> <td> Haemophilus influenzae type b vaccine, conjugate NOS</td> <td> added v2.3</td> </tr> <tr> <td> 18 <a name="18"> </a> </td> <td> rabies, intramuscular injection</td> <td> hondsdolheid, intramusculaire injectie</td> <td> rabies vaccine, for intramuscular injection</td> <td> added v2.3</td> </tr> <tr> <td> 19 <a name="19"> </a> </td> <td> BCG</td> <td> BCG</td> <td> Bacillus Calmette-Guerin vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 20 <a name="20"> </a> </td> <td> DTaP</td> <td> DaKT -difterie-acellulaire kinkhoest-tetanus</td> <td> diphtheria, tetanus toxoids and acellular pertussis vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 21 <a name="21"> </a> </td> <td> varicella</td> <td> varicella</td> <td> varicella virus vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 22 <a name="22"> </a> </td> <td> DTP-Hib</td> <td> DKT-Hib</td> <td> DTP-Haemophilus influenzae type b conjugate vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 23 <a name="23"> </a> </td> <td> plague</td> <td> pest</td> <td> plague vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 24 <a name="24"> </a> </td> <td> anthrax</td> <td> miltvuur</td> <td> anthrax vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 25 <a name="25"> </a> </td> <td> typhoid, oral</td> <td> tyfus, oral</td> <td> typhoid vaccine, live, oral</td> <td> added v2.3</td> </tr> <tr> <td> 26 <a name="26"> </a> </td> <td> cholera</td> <td> cholera</td> <td> cholera vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 27 <a name="27"> </a> </td> <td> botulinum antitoxin</td> <td> botulisme antitoxine</td> <td> botulinum antitoxin</td> <td> added v2.3</td> </tr> <tr> <td> 28 <a name="28"> </a> </td> <td> DT (pediatric)</td> <td> DT - difterie-tetanus (pediatrie)</td> <td> diphtheria and tetanus toxoids, adsorbed for pediatric use</td> <td> added v2.3</td> </tr> <tr> <td> 29 <a name="29"> </a> </td> <td> CMVIG</td> <td> CMVIG</td> <td> cytomegalovirus immune globulin, intravenous</td> <td> added v2.3</td> </tr> <tr> <td> 30 <a name="30"> </a> </td> <td> HBIG</td> <td> HBIG</td> <td> hepatitis B immune globulin</td> <td> added v2.3</td> </tr> <tr> <td> 31 <a name="31"> </a> </td> <td> Hep A, pediatric, NOS</td> <td> Hep A, pediatrie, niet anders gespecificeerd</td> <td> hepatitis A vaccine, pediatric dosage, NOS</td> <td> added v2.3</td> </tr> <tr> <td> 32 <a name="32"> </a> </td> <td> meningococcal</td> <td> meningokokken</td> <td> meningococcal polysaccharide vaccine (MPSV4)</td> <td> added v2.3</td> </tr> <tr> <td> 33 <a name="33"> </a> </td> <td> pneumococcal</td> <td> pneumokokken</td> <td> pneumococcal polysaccharide vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 34 <a name="34"> </a> </td> <td> RIG</td> <td> hondsdolheid immunoglobuline</td> <td> rabies immune globulin</td> <td> added v2.3</td> </tr> <tr> <td> 35 <a name="35"> </a> </td> <td> tetanus toxoid</td> <td> tetanus toxoïde</td> <td> tetanus toxoid, adsorbed</td> <td> added v2.3</td> </tr> <tr> <td> 36 <a name="36"> </a> </td> <td> VZIG</td> <td> VZIG</td> <td> varicella zoster immune globulin</td> <td> added v2.3</td> </tr> <tr> <td> 37 <a name="37"> </a> </td> <td> yellow fever</td> <td> gele koorts</td> <td> yellow fever vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 38 <a name="38"> </a> </td> <td> rubella/mumps</td> <td> rodehond/bof</td> <td> rubella and mumps virus vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 39 <a name="39"> </a> </td> <td> Japanese encephalitis</td> <td> Japanse encefalitis</td> <td> Japanese encephalitis vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 40 <a name="40"> </a> </td> <td> rabies, intradermal injection</td> <td> hondsdolheid, intradermale injectie</td> <td> rabies vaccine, for intradermal injection</td> <td> added v2.3</td> </tr> <tr> <td> 41 <a name="41"> </a> </td> <td> typhoid, parenteral</td> <td> tyfus, parenteraal</td> <td> typhoid vaccine, parenteral, other than acetone-killed, dried</td> <td> added v2.3</td> </tr> <tr> <td> 42 <a name="42"> </a> </td> <td> Hep B, adolescent/high risk infant2</td> <td> Hep B, adolescent/hoogrisico zuigeling2</td> <td> hepatitis B vaccine, adolescent/high risk infant dosage</td> <td> added v2.3</td> </tr> <tr> <td> 43 <a name="43"> </a> </td> <td> Hep B, adult4</td> <td> Hep B, volwassen4</td> <td> hepatitis B vaccine, adult dosage</td> <td> added v2.3</td> </tr> <tr> <td> 44 <a name="44"> </a> </td> <td> Hep B, dialysis</td> <td> Hep B, dialyse</td> <td> hepatitis B vaccine, dialysis patient dosage</td> <td> added v2.3</td> </tr> <tr> <td> 45 <a name="45"> </a> </td> <td> Hep B, NOS</td> <td> Hep B, niet anders gespecificeerd</td> <td> hepatitis B vaccine, NOS</td> <td> added v2.3</td> </tr> <tr> <td> 46 <a name="46"> </a> </td> <td> Hib (PRP-D)</td> <td> Hib (PRP-D)</td> <td> Haemophilus influenzae type b vaccine, PRP-D conjugate</td> <td> added v2.3</td> </tr> <tr> <td> 47 <a name="47"> </a> </td> <td> Hib (HbOC)</td> <td> Hib (HbOC)</td> <td> Haemophilus influenzae type b vaccine, HbOC conjugate</td> <td> added v2.3</td> </tr> <tr> <td> 48 <a name="48"> </a> </td> <td> Hib (PRP-T)</td> <td> Hib (PRP-T)</td> <td> Haemophilus influenzae type b vaccine, PRP-T conjugate</td> <td> added v2.3</td> </tr> <tr> <td> 49 <a name="49"> </a> </td> <td> Hib (PRP-OMP)</td> <td> Hib (PRP-OMP)</td> <td> Haemophilus influenzae type b vaccine, PRP-OMP conjugate</td> <td> added v2.3</td> </tr> <tr> <td> 50 <a name="50"> </a> </td> <td> DTaP-Hib</td> <td> DaKT-Hib</td> <td> DTaP-Haemophilus influenzae type b conjugate vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 51 <a name="51"> </a> </td> <td> Hib-Hep B</td> <td> Hib-Hep B</td> <td> Haemophilus influenzae type b conjugate and Hepatitis B vaccine</td> <td> added v2.3</td> </tr> <tr> <td> 52 <a name="52"> </a> </td> <td> Hep A, adult</td> <td> Hep A, volwassene</td> <td> hepatitis A vaccine, adult dosage</td> <td> added v2.3</td> </tr> <tr> <td> 53 <a name="53"> </a> </td> <td> typhoid, parenteral, AKD (U.S. military)</td> <td> tyfus, parenteraal, AKD (Amerikaanse leger)</td> <td> typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)</td> <td> added v2.3.1</td> </tr> <tr> <td> 54 <a name="54"> </a> </td> <td> adenovirus, type 4</td> <td> adenovirus, type 4</td> <td> adenovirus vaccine, type 4, live, oral</td> <td> added v2.3.1</td> </tr> <tr> <td> 55 <a name="55"> </a> </td> <td> adenovirus, type 7</td> <td> adenovirus, type 7</td> <td> adenovirus vaccine, type 7, live, oral</td> <td> added v2.3.1</td> </tr> <tr> <td> 56 <a name="56"> </a> </td> <td> dengue fever</td> <td> knokkelkoorts</td> <td> dengue fever vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 57 <a name="57"> </a> </td> <td> hantavirus</td> <td> hantavirus</td> <td> hantavirus vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 58 <a name="58"> </a> </td> <td> Hep C</td> <td> Hep C</td> <td> hepatitis C vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 59 <a name="59"> </a> </td> <td> Hep E</td> <td> Hep E</td> <td> hepatitis E vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 60 <a name="60"> </a> </td> <td> herpes simplex 2</td> <td> herpes simplex 2</td> <td> herpes simplex virus, type 2 vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 61 <a name="61"> </a> </td> <td> HIV</td> <td> HIV</td> <td> human immunodeficiency virus vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 62 <a name="62"> </a> </td> <td> HPV, quadrivalent</td> <td> HPV, quadrivalent</td> <td> human papilloma virus vaccine, quadrivalent</td> <td> added v2.3.1</td> </tr> <tr> <td> 63 <a name="63"> </a> </td> <td> Junin virus</td> <td> Junín virus</td> <td> Junin virus vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 64 <a name="64"> </a> </td> <td> leishmaniasis</td> <td> leishmaniase</td> <td> leishmaniasis vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 65 <a name="65"> </a> </td> <td> leprosy</td> <td> lepra</td> <td> leprosy vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 66 <a name="66"> </a> </td> <td> Lyme disease</td> <td> ziekte van Lyme</td> <td> Lyme disease vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 67 <a name="67"> </a> </td> <td> malaria</td> <td> malaria</td> <td> malaria vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 68 <a name="68"> </a> </td> <td> melanoma</td> <td> melanoom</td> <td> melanoma vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 69 <a name="69"> </a> </td> <td> parainfluenza-3</td> <td> parainfluenza-3</td> <td> parainfluenza-3 virus vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 70 <a name="70"> </a> </td> <td> Q fever</td> <td> Q-koorts</td> <td> Q fever vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 71 <a name="71"> </a> </td> <td> RSV-IGIV</td> <td> RSV-IGIV</td> <td> respiratory syncytial virus immune globulin, intravenous</td> <td> added v2.3.1</td> </tr> <tr> <td> 72 <a name="72"> </a> </td> <td> rheumatic fever</td> <td> reumatische koorts</td> <td> rheumatic fever vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 73 <a name="73"> </a> </td> <td> Rift Valley fever</td> <td> Riftdalkoorts</td> <td> Rift Valley fever vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 74 <a name="74"> </a> </td> <td> rotavirus, tetravalent</td> <td> rotavirus, tetravalent</td> <td> rotavirus, live, tetravalent vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 75 <a name="75"> </a> </td> <td> vaccinia (smallpox)</td> <td> vaccinia (pokken)</td> <td> vaccinia (smallpox) vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 76 <a name="76"> </a> </td> <td> Staphylococcus bacterio lysate</td> <td> Staphylococcus bacterio lysate</td> <td> Staphylococcus bacteriophage lysate</td> <td> added v2.3.1</td> </tr> <tr> <td> 77 <a name="77"> </a> </td> <td> tick-borne encephalitis</td> <td> frühsommer-meningoenzephalitis vaccin</td> <td> tick-borne encephalitis vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 78 <a name="78"> </a> </td> <td> tularemia vaccine</td> <td> tularemia vaccin</td> <td> tularemia vaccine</td> <td> added v2.3.1</td> </tr> <tr> <td> 79 <a name="79"> </a> </td> <td> vaccinia immune globulin</td> <td> vaccinia immunoglobuline</td> <td> vaccinia immune globulin</td> <td> added v2.3.1</td> </tr> <tr> <td> 80 <a name="80"> </a> </td> <td> VEE, live</td> <td> VEE, levend</td> <td> Venezuelan equine encephalitis, live, attenuated</td> <td> added v2.3.1</td> </tr> <tr> <td> 81 <a name="81"> </a> </td> <td> VEE, inactivated</td> <td> VEE, inactief</td> <td> Venezuelan equine encephalitis, inactivated</td> <td> added v2.3.1</td> </tr> <tr> <td> 82 <a name="82"> </a> </td> <td> adenovirus, NOS1</td> <td> adenovirus, niet anders gespecificeerd1</td> <td> adenovirus vaccine, NOS</td> <td> added v2.3.1</td> </tr> <tr> <td> 83 <a name="83"> </a> </td> <td> Hep A, ped/adol, 2 dose</td> <td> Hep A, ped/adol, 2 dosis</td> <td> hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule</td> <td> added v2.3.1</td> </tr> <tr> <td> 84 <a name="84"> </a> </td> <td> Hep A, ped/adol, 3 dose</td> <td> Hep A, ped/adol, 3 dosis</td> <td> hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule</td> <td> added v2.3.1</td> </tr> <tr> <td> 85 <a name="85"> </a> </td> <td> Hep A, NOS</td> <td> Hep A, niet anders gespecificeerd</td> <td> hepatitis A vaccine, NOS</td> <td> added v2.3.1</td> </tr> <tr> <td> 86 <a name="86"> </a> </td> <td> IG</td> <td> IG</td> <td> immune globulin, intramuscular</td> <td> added v2.3.1</td> </tr> <tr> <td> 87 <a name="87"> </a> </td> <td> IGIV</td> <td> IGIV</td> <td> immune globulin, intravenous</td> <td> added v2.3.1</td> </tr> <tr> <td> 88 <a name="88"> </a> </td> <td> influenza, NOS</td> <td> influenza, niet anders gespecificeerd</td> <td> influenza virus vaccine, NOS</td> <td> added v2.3.1</td> </tr> <tr> <td> 89 <a name="89"> </a> </td> <td> polio, NOS</td> <td> polio, niet anders gespecificeerd</td> <td> poliovirus vaccine, NOS</td> <td> added v2.3.1</td> </tr> <tr> <td> 90 <a name="90"> </a> </td> <td> rabies, NOS</td> <td> hondsdolheid, niet anders gespecificeerd</td> <td> rabies vaccine, NOS</td> <td> added v2.3.1</td> </tr> <tr> <td> 91 <a name="91"> </a> </td> <td> typhoid, NOS</td> <td> tyfus, niet anders gespecificeerd</td> <td> typhoid vaccine, NOS</td> <td> added v2.3.1</td> </tr> <tr> <td> 92 <a name="92"> </a> </td> <td> VEE, NOS</td> <td> VEE, niet anders gespecificeerd</td> <td> Venezuelan equine encephalitis vaccine, NOS</td> <td> added v2.3.1</td> </tr> <tr> <td> 93 <a name="93"> </a> </td> <td> RSV-MAb</td> <td> RSV-MAb</td> <td> respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular</td> <td> added v2.4</td> </tr> <tr> <td> 94 <a name="94"> </a> </td> <td> MMRV</td> <td> BMRV - bof, mazelen, rodehond en varicella</td> <td> measles, mumps, rubella, and varicella virus vaccine</td> <td> added v2.4</td> </tr> <tr> <td> 95 <a name="95"> </a> </td> <td> TST-OT tine test</td> <td> TST-OT tine test</td> <td> tuberculin skin test; old tuberculin, multipuncture device</td> <td> added v2.4</td> </tr> <tr> <td> 96 <a name="96"> </a> </td> <td> TST-PPD intradermal</td> <td> TST-PPD intradermal</td> <td> tuberculin skin test; purified protein derivative solution, intradermal</td> <td> added v2.4</td> </tr> <tr> <td> 97 <a name="97"> </a> </td> <td> TST-PPD tine test</td> <td> TST-PPD tine test</td> <td> tuberculin skin test; purified protein derivative, multipuncture device</td> <td> added v2.4</td> </tr> <tr> <td> 98 <a name="98"> </a> </td> <td> TST, NOS</td> <td> TST, niet anders gespecificeerd</td> <td> tuberculin skin test; NOS</td> <td> added v2.4</td> </tr> <tr> <td> 99 <a name="99"> </a> </td> <td> RESERVED - do not use3</td> <td> GERESERVEERD - niet gebruiken3</td> <td> RESERVED - do not use</td> <td> added v2.4</td> </tr> <tr> <td> 998 <a name="998"> </a> </td> <td> no vaccine administered5</td> <td> geen vaccin toegediend5</td> <td> no vaccine administered</td> <td> added v2.5</td> </tr> <tr> <td> 999 <a name="999"> </a> </td> <td> unknown</td> <td> onbekend</td> <td> unknown vaccine or immune globulin</td> <td> added v2.4</td> </tr> </table> </div> </text> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status"> <valueString value="External"/> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"> <valueInteger value="0"/> </extension> <url value="http://hl7.org/fhir/ValueSet/v2-0292"/> <version value="2.8.2"/> <name value="v2 Vaccines Administered (code = CVX) (parenteral, un"/> <status value="active"/> <experimental value="false"/> <publisher value="HL7, Inc"/> <contact> <telecom> <system value="url"/> <value value="http://hl7.org"/> </telecom> </contact> <description value="FHIR Value set/code system definition for HL7 v2 table 0292 ( Vaccines Administered (code = CVX) (parenteral, un)"/> <immutable value="true"/> <compose> <include> <system value="http://hl7.org/fhir/v2/0292"/> </include> </compose> </ValueSet>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.